Selected research
Market Structure
Global Antibacterial Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Antibacterial Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Antibacterial Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Antibacterial Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Antibacterial Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Antibacterial Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Antibacterial Vaccines include Sanofi Pasteur, Novartis Vaccines, Merck & Co., Wyeth Pharmaceuticals, Inc., Protein Sciences Co., Organon Teknika Co., MedImmune LLC, MassBiologics and Intercell Biomedical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Antibacterial Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Antibacterial Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Antibacterial Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antibacterial Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.
Antibacterial Vaccines Segment by Company
Sanofi Pasteur
Novartis Vaccines
Merck & Co.
Wyeth Pharmaceuticals, Inc.
Protein Sciences Co.
Organon Teknika Co.
MedImmune LLC
MassBiologics
Intercell Biomedical
ID Biomedical Co.
GlaxoSmithKline Biologicals
Emergent BioDefense Operations Lansing Inc.
Diagnostics Ltd.
CSL Ltd.
Berna Biotech
Barr Labs, Inc.
Antibacterial Vaccines Segment by Type
Conjugate Vaccines
Live/attenuated Vaccines
Inactivated Vaccines
Antibacterial Vaccines Segment by Application
Bacterial Diseases
Viral Diseases
Antibacterial Vaccines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibacterial Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antibacterial Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibacterial Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Antibacterial Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibacterial Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antibacterial Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Antibacterial Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Conjugate Vaccines
- Live/attenuated Vaccines
- Inactivated Vaccines
Applications
- Bacterial Diseases
- Viral Diseases
Companies covered
- Sanofi Pasteur
- Novartis Vaccines
- Merck & Co.
- Wyeth Pharmaceuticals, Inc.
- Protein Sciences Co.
- Organon Teknika Co.
- MedImmune LLC
- MassBiologics
- Intercell Biomedical
- ID Biomedical Co.
- GlaxoSmithKline Biologicals
- Emergent BioDefense Operations Lansing Inc.
- Diagnostics Ltd.
- CSL Ltd.
- Berna Biotech
- Barr Labs, Inc.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Antibacterial Vaccines Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Antibacterial Vaccines Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Antibacterial Vaccines Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Antibacterial Vaccines Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Antibacterial Vaccines Market Dynamics
- 2.1 Antibacterial Vaccines Industry Trends
- 2.2 Antibacterial Vaccines Industry Drivers
- 2.3 Antibacterial Vaccines Industry Opportunities and Challenges
- 2.4 Antibacterial Vaccines Industry Restraints
3 Antibacterial Vaccines Market by Manufacturers
- 3.1 Global Antibacterial Vaccines Revenue by Manufacturers (2021-2026)
- 3.2 Global Antibacterial Vaccines Sales by Manufacturers (2021-2026)
- 3.3 Global Antibacterial Vaccines Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Antibacterial Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Antibacterial Vaccines Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Antibacterial Vaccines Manufacturers, Product Type & Application
- 3.7 Global Antibacterial Vaccines Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Antibacterial Vaccines Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Antibacterial Vaccines Players Market Share by Revenue in 2025
- 3.8.3 2025 Antibacterial Vaccines Tier 1, Tier 2, and Tier 3
4 Antibacterial Vaccines Market by Type
- 4.1 Antibacterial Vaccines Type Introduction
- 4.1.1 Conjugate Vaccines
- 4.1.2 Live/attenuated Vaccines
- 4.1.3 Inactivated Vaccines
- 4.2 Global Antibacterial Vaccines Sales by Type
- 4.2.1 Global Antibacterial Vaccines Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Antibacterial Vaccines Sales by Type (2021-2032)
- 4.2.3 Global Antibacterial Vaccines Sales Market Share by Type (2021-2032)
- 4.3 Global Antibacterial Vaccines Revenue by Type
- 4.3.1 Global Antibacterial Vaccines Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Antibacterial Vaccines Revenue by Type (2021-2032)
- 4.3.3 Global Antibacterial Vaccines Revenue Market Share by Type (2021-2032)
5 Antibacterial Vaccines Market by Application
- 5.1 Antibacterial Vaccines Application Introduction
- 5.1.1 Bacterial Diseases
- 5.1.2 Viral Diseases
- 5.2 Global Antibacterial Vaccines Sales by Application
- 5.2.1 Global Antibacterial Vaccines Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Antibacterial Vaccines Sales by Application (2021-2032)
- 5.2.3 Global Antibacterial Vaccines Sales Market Share by Application (2021-2032)
- 5.3 Global Antibacterial Vaccines Revenue by Application
- 5.3.1 Global Antibacterial Vaccines Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Antibacterial Vaccines Revenue by Application (2021-2032)
- 5.3.3 Global Antibacterial Vaccines Revenue Market Share by Application (2021-2032)
6 Global Antibacterial Vaccines Sales by Region
- 6.1 Global Antibacterial Vaccines Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Antibacterial Vaccines Sales by Region (2021-2032)
- 6.2.1 Global Antibacterial Vaccines Sales by Region (2021-2026)
- 6.2.2 Global Antibacterial Vaccines Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Antibacterial Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Antibacterial Vaccines Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Antibacterial Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Antibacterial Vaccines Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Antibacterial Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Antibacterial Vaccines Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Antibacterial Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Antibacterial Vaccines Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Antibacterial Vaccines Revenue by Region
- 7.1 Global Antibacterial Vaccines Revenue by Region
- 7.1.1 Global Antibacterial Vaccines Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Antibacterial Vaccines Revenue by Region (2021-2026)
- 7.1.3 Global Antibacterial Vaccines Revenue by Region (2027-2032)
- 7.1.4 Global Antibacterial Vaccines Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Antibacterial Vaccines Revenue (2021-2032)
- 7.2.2 North America Antibacterial Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Antibacterial Vaccines Revenue (2021-2032)
- 7.3.2 Europe Antibacterial Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Antibacterial Vaccines Revenue (2021-2032)
- 7.4.2 Asia-Pacific Antibacterial Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Antibacterial Vaccines Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Antibacterial Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Sanofi Pasteur
- 8.1.1 Sanofi Pasteur Company Information
- 8.1.2 Sanofi Pasteur Business Overview
- 8.1.3 Sanofi Pasteur Antibacterial Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Sanofi Pasteur Antibacterial Vaccines Product Portfolio
- 8.1.5 Sanofi Pasteur Recent Developments
- 8.2 Novartis Vaccines
- 8.2.1 Novartis Vaccines Company Information
- 8.2.2 Novartis Vaccines Business Overview
- 8.2.3 Novartis Vaccines Antibacterial Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Novartis Vaccines Antibacterial Vaccines Product Portfolio
- 8.2.5 Novartis Vaccines Recent Developments
- 8.3 Merck & Co.
- 8.3.1 Merck & Co. Company Information
- 8.3.2 Merck & Co. Business Overview
- 8.3.3 Merck & Co. Antibacterial Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Merck & Co. Antibacterial Vaccines Product Portfolio
- 8.3.5 Merck & Co. Recent Developments
- 8.4 Wyeth Pharmaceuticals, Inc.
- 8.4.1 Wyeth Pharmaceuticals, Inc. Company Information
- 8.4.2 Wyeth Pharmaceuticals, Inc. Business Overview
- 8.4.3 Wyeth Pharmaceuticals, Inc. Antibacterial Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Wyeth Pharmaceuticals, Inc. Antibacterial Vaccines Product Portfolio
- 8.4.5 Wyeth Pharmaceuticals, Inc. Recent Developments
- 8.5 Protein Sciences Co.
- 8.5.1 Protein Sciences Co. Company Information
- 8.5.2 Protein Sciences Co. Business Overview
- 8.5.3 Protein Sciences Co. Antibacterial Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Protein Sciences Co. Antibacterial Vaccines Product Portfolio
- 8.5.5 Protein Sciences Co. Recent Developments
- 8.6 Organon Teknika Co.
- 8.6.1 Organon Teknika Co. Company Information
- 8.6.2 Organon Teknika Co. Business Overview
- 8.6.3 Organon Teknika Co. Antibacterial Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Organon Teknika Co. Antibacterial Vaccines Product Portfolio
- 8.6.5 Organon Teknika Co. Recent Developments
- 8.7 MedImmune LLC
- 8.7.1 MedImmune LLC Company Information
- 8.7.2 MedImmune LLC Business Overview
- 8.7.3 MedImmune LLC Antibacterial Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 MedImmune LLC Antibacterial Vaccines Product Portfolio
- 8.7.5 MedImmune LLC Recent Developments
- 8.8 MassBiologics
- 8.8.1 MassBiologics Company Information
- 8.8.2 MassBiologics Business Overview
- 8.8.3 MassBiologics Antibacterial Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 MassBiologics Antibacterial Vaccines Product Portfolio
- 8.8.5 MassBiologics Recent Developments
- 8.9 Intercell Biomedical
- 8.9.1 Intercell Biomedical Company Information
- 8.9.2 Intercell Biomedical Business Overview
- 8.9.3 Intercell Biomedical Antibacterial Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Intercell Biomedical Antibacterial Vaccines Product Portfolio
- 8.9.5 Intercell Biomedical Recent Developments
- 8.10 ID Biomedical Co.
- 8.10.1 ID Biomedical Co. Company Information
- 8.10.2 ID Biomedical Co. Business Overview
- 8.10.3 ID Biomedical Co. Antibacterial Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 ID Biomedical Co. Antibacterial Vaccines Product Portfolio
- 8.10.5 ID Biomedical Co. Recent Developments
- 8.11 GlaxoSmithKline Biologicals
- 8.11.1 GlaxoSmithKline Biologicals Company Information
- 8.11.2 GlaxoSmithKline Biologicals Business Overview
- 8.11.3 GlaxoSmithKline Biologicals Antibacterial Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 GlaxoSmithKline Biologicals Antibacterial Vaccines Product Portfolio
- 8.11.5 GlaxoSmithKline Biologicals Recent Developments
- 8.12 Emergent BioDefense Operations Lansing Inc.
- 8.12.1 Emergent BioDefense Operations Lansing Inc. Company Information
- 8.12.2 Emergent BioDefense Operations Lansing Inc. Business Overview
- 8.12.3 Emergent BioDefense Operations Lansing Inc. Antibacterial Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Emergent BioDefense Operations Lansing Inc. Antibacterial Vaccines Product Portfolio
- 8.12.5 Emergent BioDefense Operations Lansing Inc. Recent Developments
- 8.13 Diagnostics Ltd.
- 8.13.1 Diagnostics Ltd. Company Information
- 8.13.2 Diagnostics Ltd. Business Overview
- 8.13.3 Diagnostics Ltd. Antibacterial Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Diagnostics Ltd. Antibacterial Vaccines Product Portfolio
- 8.13.5 Diagnostics Ltd. Recent Developments
- 8.14 CSL Ltd.
- 8.14.1 CSL Ltd. Company Information
- 8.14.2 CSL Ltd. Business Overview
- 8.14.3 CSL Ltd. Antibacterial Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 CSL Ltd. Antibacterial Vaccines Product Portfolio
- 8.14.5 CSL Ltd. Recent Developments
- 8.15 Berna Biotech
- 8.15.1 Berna Biotech Company Information
- 8.15.2 Berna Biotech Business Overview
- 8.15.3 Berna Biotech Antibacterial Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Berna Biotech Antibacterial Vaccines Product Portfolio
- 8.15.5 Berna Biotech Recent Developments
- 8.16 Barr Labs, Inc.
- 8.16.1 Barr Labs, Inc. Company Information
- 8.16.2 Barr Labs, Inc. Business Overview
- 8.16.3 Barr Labs, Inc. Antibacterial Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Barr Labs, Inc. Antibacterial Vaccines Product Portfolio
- 8.16.5 Barr Labs, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Antibacterial Vaccines Value Chain Analysis
- 9.1.1 Antibacterial Vaccines Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Antibacterial Vaccines Production Mode & Process
- 9.2 Antibacterial Vaccines Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Antibacterial Vaccines Distributors
- 9.2.3 Antibacterial Vaccines Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst